Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | -15,538 | 0 | 0 | 0 |
| Depreciation Amortization | 0 | 4,010 | 0 | 0 | 0 |
| Other Working Capital | 0 | 8,409 | 0 | 0 | 0 |
| Other Operating Activity | -6,170 | 360 | -25,146 | -11,523 | -5,644 |
| Operating Cash Flow | $-6,170 | $-2,759 | $-25,146 | $-11,523 | $-5,644 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -440 | -5,875 | -4,729 | -3,841 | -2,755 |
| Net Acquisitions | 0 | 0 | -3,000 | 0 | 0 |
| Other Investing Activity | -6,990 | 15,686 | 12,293 | 2,227 | 1,104 |
| Investing Cash Flow | $-7,430 | $9,811 | $4,564 | $-1,614 | $-1,651 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 390 | 2,458 | 2,634 | -576 | -187 |
| Financing Cash Flow | $390 | $2,458 | $2,634 | $-576 | $-187 |
| Beginning Cash Position | 34,840 | 25,337 | 25,337 | 25,337 | 25,337 |
| End Cash Position | 21,630 | 34,847 | 7,389 | 11,624 | 17,855 |
| Net Cash Flow | $-13,210 | $9,510 | $-17,948 | $-13,713 | $-7,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,170 | -2,759 | -25,146 | -11,523 | -5,644 |
| Free Cash Flow | -6,170 | -2,759 | -25,146 | -11,523 | -5,644 |